AustinPx is a fee-for-service CDMO offering drug development of oral dosage forms. We specialize in bioavailability enhancement, including our next generation amorphous dispersion platform, KinetiSolTM Technology. Our drug development support includes (pre-IND through phase 3), manufacturing, analytical and formulation development, clinical trial material manufacturing, packaging, and labeling to pharmaceutical customers globally.